Details

Last Funding Type

Debt Financing

Last Funding Money Raised

$20M

Industries

Health Care,Medical Device,Pharmaceutical

Founded date

Jan 1, 2004

Number Of Employee

11 - 50

Operating Status

Active

nContact is a medical device company founded in 2005 with a mission to develop devices for the endoscopic treatment of arrhythmias, including atrial fibrillation (AF). The Numeris® Coagulation System with VisiTrax® is based on the unique integration of suction, perfusion, and RF energy to ensure the creation of visible, nonconductive, continuous, bi-atrial lesions on the epicardium of a beating heart.

To date, the Numeris® Coagulation System with VisiTrax® is indicated for endoscopic coagulation of cardiac tissue in the United States. nContact has initiated IDE clinical studies for the treatment of AF in both open and closed chest procedures. The Numeris Coagulation System with VisiTrax has CE Mark approval in
Europe for the coagulation of cardiac tissue for the treatment of AF and atrial flutter.